Clinical Trial Update: The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial [NA]

View source ↗

Summary

The ASPECT study evaluating a paclitaxel-eluting stent for coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• ASPECT Paclitaxel-Eluting Stent (paclitaxel-eluting stent)

Snippet

Sponsor: Cook Group Incorporated | Conditions: Coronary Artery Disease | NA | Status: COMPLETED